Evidence map›Paper›PMID 33981489›Full record

ArticlePeerJ2021

Commercial arbuscular mycorrhizal fungal inoculant failed to establish in a vineyard despite priority advantage.

Corrina Thomsen, Laura Loverock, Vasilis Kokkoris, Taylor Holland, Patricia A Bowen, Miranda Hart

Abstract read
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Corrina ThomsenDepartment of Biology, University of British Columbia Okanagan, Kelowna, BC, Canada.
Laura LoverockDepartment of Biology, University of British Columbia Okanagan, Kelowna, BC, Canada.
Vasilis KokkorisDepartment of Biology, University of Ottawa, Ottawa, ON, Canada.
Taylor HollandDepartment of Biology, University of British Columbia Okanagan, Kelowna, BC, Canada.
Patricia A BowenSummerland Research and Development Centre, Agriculture and Agri-food Canada, Summerland, BC, Canada.
Miranda HartDepartment of Biology, University of British Columbia Okanagan, Kelowna, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArbuscular mycorrhizal (AM) fungi associate with most plants and can increase nutrient uptake. As a result, commercial inoculants called "biofertilizers" containing AM fungi have been developed and marketed to increase plant performance. However, successful establishment of these inoculants remains a challenge, and may be negatively impacted by competition with fungi already present (priority effects). Perennial agriculture may be more amenable if inoculants can be successfully established on crops prior to field planting.

methodsHere, we inoculate grapevine (

resultsWe found that the introduced strain did not establish in any treatment, even with priority advantage, and inoculated vines did not differ in performance from non-inoculated vines. Fungal abundance was not greater than in pre-inoculation soil samples during any of the five years sampled and may have been impaired by high available phosphorus levels in the soil. This study highlights the need to understand and evaluate how the management of the agricultural system will affect establishment before introduction of "biofertilizers", which is often unpredictable.

Indexed as

Arbuscular mycorrhizal fungiBiofertilizerInoculantsPriority effectRoot colonizationSoilcolonization

Identifiers

PMID33981489
PMCPMC8071076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.